| Titels | Prof. dr. |
| Initials | P.C.W. |
| Main position | Hoogleraar UL / Decaan LUMC |
| Disciplines | Pathology, pathological anatomy |
| Oncology | |
| Medicine | |
| Chair | Pathologie |
| Domain | Medical, Biomedical and Health Sciences |
| Membership | Member |
| Since | 2021 |
| Member of Medical, Biomedical and Health Sciences | |
| Employed by |
Leids Universitair Medisch Centrum
L1Q Postbus 9600 2300 RC Leiden tel. 071 526 2595 p.c.w.hogendoorn@lumc.nl |
| Personal website | |
| Research/publications |
Pancras Hogendoorn is renowned for his pioneering research into molecular-genetic and clinical pathogenesis of human bone and soft-tissue tumours. His work has led to precision diagnostics and treatment for patients who previously had few therapeutic options. The World Health Organisation (WHO) recognised the significance of Hogendoorn’s work in 2002 by inviting him to join the working group that classifies bone and soft-tissue tumours, a role in which he has worked to improve research into and treatment of these rare tumours around the world. In addition to his research, Hogendoorn is also a prominent ambassador for science. For example, he is a co-founder of the Dutch National Research Agenda, the Chief Scientific Officer of the Life Sciences & Health Top Team (an alliance between science, industry and government), and the chairman of the League of the European Research Universities (LERU) Policy Group in Biomedicine.